Plain-English translation of NCT04187443 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new medication called that you would take by mouth to treat diabetic macular edema — a type of eye swelling caused by diabetes that can affect your vision. The study will enroll 45 people and test three different doses of the medication to see which is safest and most effective.
Diabetic eye swelling can damage vision and currently requires injections or laser treatments that not all patients can have or want. This medication aims to offer a simpler oral option to reduce swelling and protect eyesight.
You likely qualify if…
You likely don't qualify if…
If you join, you will take the medication by mouth once daily for 8 weeks. You'll be assigned to one of three groups that test different doses — doctors will start with lower doses and increase them as they monitor safety. You'll have regular eye exams and vision tests to see how well the treatment is working and to watch for any side effects.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China